Re: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?
Bhutani
Manisha
M
Pathak
Ashutosh Kumar
AK
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000975:Antioxidants / Q000008:administration & dosage* / Q000009:adverse effects* / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D002986:Clinical Trials as Topic; D019587:Dietary Supplements / Q000009:adverse effects*; D004334:Drug Administration Schedule; D019317:Evidence-Based Medicine; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D018384:Oxidative Stress / Q000187:drug effects / Q000528:radiation effects; D012107:Research Design; D018401:Sample Size; D015996:Survival Rate; D016896:Treatment Outcome
D000975:Antioxidants